
TEPEZZA
TEPEZZA (teprotumumab-trbw) is an insulin-like growth factor-1 receptor inhibitor used to treat Thyroid Eye Disease, an autoimmune disease characterized by proptosis (a condition where the eyes are pushed forward and bulge outward) leading to eye pain, double vision, and difficulty closing the eyelid.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
What it treats
Thyroid Eye Disease (TED)
Prescribed by
Ophthalmologists
How it’s administered
Intravenous (IV) infusion
Frequency
Once every three weeks for eight doses
Length of treatment
About 90 minutes